Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies ; volume:48 ; number:3 ; year:2021 ; pages:137-147 ; extent:11
Transfusion medicine and hemotherapy ; 48, Heft 3 (2021), 137-147 (gesamt 11)
- Creator
-
Körper, Sixten
Jahrsdörfer, Bernd
Corman, Victor M.
Pilch, Jan
Wuchter, Patrick
Blasczyk, Rainer
Müller, Rebecca
Tonn, Torsten
Bakchoul, Tamam
Schäfer, Richard
Juhl, David
Schwarz, Tatjana
Gödecke, Nina
Burkhardt, Thomas
Schmidt, Michael
Appl, Thomas
Eichler, Hermann
Klüter, Harald
Drosten, Christian
Seifried, Erhard
Schrezenmeier, Hubert
- DOI
-
10.1159/000515610
- URN
-
urn:nbn:de:101:1-2021061000140203724892
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Körper, Sixten
- Jahrsdörfer, Bernd
- Corman, Victor M.
- Pilch, Jan
- Wuchter, Patrick
- Blasczyk, Rainer
- Müller, Rebecca
- Tonn, Torsten
- Bakchoul, Tamam
- Schäfer, Richard
- Juhl, David
- Schwarz, Tatjana
- Gödecke, Nina
- Burkhardt, Thomas
- Schmidt, Michael
- Appl, Thomas
- Eichler, Hermann
- Klüter, Harald
- Drosten, Christian
- Seifried, Erhard
- Schrezenmeier, Hubert
Other Objects (12)
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies